Biotype Diagnostic GmbH
Records under this name other than the patents Biotype Diagnostic GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 6 of 6 · Back to Biotype Diagnostic GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,669,573 | Confirmation test for primary nucleic acid amplification products in a continuous reaction setup and immediate analysis via immunochromatographic methods Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,368,246 | Quantitative gene expression profiling Term ended Term ended Jan 8, 2026 · USPTO record | Term ended | Term ended Jan 8, 2026 | USPTO record |
| US 7,081,339 | Methods for variation detection Term ended Term ended Jul 25, 2024 · USPTO record | Term ended | Term ended Jul 25, 2024 | USPTO record |
| US 7,445,893 | Sampling method for amplification reaction analysis Term ended Term ended May 24, 2023 · USPTO record | Term ended | Term ended May 24, 2023 | USPTO record |
| US 7,674,582 | Methods for amplification monitoring and gene expression profiling, involving real time amplification reaction sampling Term ended Ended no later than Mar 12, 2023 · USPTO record | Term ended | Ended no later than Mar 12, 2023 | USPTO record |
| US 8,182,995 | Real time gene expression profiling Term ended Ended no later than Mar 12, 2023 · USPTO record | Term ended | Ended no later than Mar 12, 2023 | USPTO record |